IPSC — Century Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $382.81m
- $265.70m
- $109.16m
Annual cashflow statement for Century Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -95.8 | -131 | -137 | -127 | -9.58 |
| Depreciation | |||||
| Non-Cash Items | 6.66 | 13.1 | 26.1 | 11.5 | 7.23 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.58 | 123 | 9.16 | -8.41 | -115 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -89 | 14.1 | -88.3 | -110 | -104 |
| Capital Expenditures | -45 | -30.6 | -13.7 | -0.154 | -0.848 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -253 | 17.5 | 74.9 | 47.6 | 108 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -298 | -13.1 | 61.1 | 47.5 | 108 |
| Financing Cash Flow Items | 34.2 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 418 | 27.2 | -9.72 | 74.6 | 0.173 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 30.4 | 28.1 | -36.9 | 11.9 | 3.8 |